Login / Signup

Postmarketing Safety Monitoring After Influenza Vaccination Using a Mobile Health App: Prospective Longitudinal Feasibility Study.

Minh Tam H NguyenGérard KrauseBrigitte Keller-StanislawskiStephan GlöcknerDirk MentzerJördis J Ott
Published in: JMIR mHealth and uHealth (2021)
Digital AEFI reporting was feasible with SafeVac and generated plausible results for this observation period and setting. Studies directly comparing SafeVac with conventional passive reporting schemes could determine whether such digital approaches improve completeness, timeliness, and sensitivity of vaccine vigilance. Further studies should evaluate if these results are transferable to other vaccinations and populations and if introduction of such a tool has an influence on vaccination readiness and therefore vaccine safety.
Keyphrases
  • case control
  • adverse drug
  • cross sectional